Stone X Group Inc. Bio Affinity Technologies, Inc. Transaction History
Stone X Group Inc.
- $2.06 Trillion
- Q2 2025
A detailed history of Stone X Group Inc. transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Stone X Group Inc. holds 15,206 shares of BIAF stock, worth $4,257. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,206Holding current value
$4,257% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
20Shares Held
416KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA125KShares$35,1280.0% of portfolio
-
Allworth Financial LP53.7KShares$15,0450.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC53.7KShares$15,0450.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.6KShares$11,3790.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$7,8070.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $764K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...